• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Nanoparticles

Scientists develop nanoparticles to ‘suffocate’ tumor cells

January 23, 2017 By Sarah Faulkner

A team of researchers from the Shanghai Institute of Ceramics, Chinese Academy of Sciences and the East China Normal University have developed polyvinyl pyrrolidone modified nanoparticles that serve as a deoxygenation agent against tumor cells. The therapy, which is described in Nature Nanotechnology, targeted cancer cells by cutting off the tumor’s blood supply to deprive and ‘suffocate’ […]

Filed Under: Featured, Nanoparticles, Oncology, Research & Development

Cytori buys Azaya’s nanoparticle tech in stock deal

January 20, 2017 By Sarah Faulkner

Cytori buys Azaya's nanoparticle tech in stock deal

Cytori Therapeutics (NSDQ:CYTX) said this week that it bought San Antonio-based Azaya Therapeutics and its nanoparticle cancer drugs in a stock deal. Azaya shareholders will receive $2 million in CTYX stock. San Diego-based Cytori will also pay $2 million upfront for costs associated with Azaya’s new manufacturing facility in San Antonio. Cytori will acquire a […]

Filed Under: Featured, Mergers & Acquisitions, Nanoparticles, Oncology, Wall Street Beat Tagged With: Azaya Therapeutics, Cytori Therapeutics

leon-nanodrugs, Bionpharma to develop microjet reactor-based dermatological product

January 17, 2017 By Sarah Faulkner

leon-nanodrugs GmbH and Bionpharma Inc. said yesterday that the 2 groups inked a deal to develop a dermatological product using leon-nanodrugs’ microjet reactor nanotechnology platform. The companies will share the development of the undisclosed product. Development will be done at leon-nanodrugs’ U.S.-based formulation partner CoreRx in Clearwater, Florida. Bionpharma will market and distribute the product […]

Filed Under: Featured, Nanoparticles, Research & Development, Wall Street Beat Tagged With: Bionpharma Inc., leon-nanodrugs GmbH

Merrimack sells liposome injections to Ipsen for $575m

January 9, 2017 By Sarah Faulkner

Merrimack sells liposome injections to Ipsen for $575m

In a deal that could earn the Cambridge, Mass.-based pharmaceutical company over $1.03 billion, Merrimack Pharmaceuticals (NSDQ:MACK) said yesterday that it is selling its liposome injection cancer drugs, Onivyde and generic Doxil, to Ipsen (EPA:IPN). Merrimack is also slashing its employee headcount down to just 80 people, after laying off 22% of its 400 employees […]

Filed Under: Featured, Immunotherapy, Mergers & Acquisitions, Nanoparticles, Oncology, Wall Street Beat Tagged With: Ipsen, Merrimack Pharmaceuticals

Keystone Nano wins FDA nod for nanoliposome cancer treatment

January 5, 2017 By Sarah Faulkner

Keystone Nano launches clinical trial for NanoLiposome cancer therapy

Keystone Nano said today that the FDA approved its investigational new drug application for the ceramide nanoliposome as a treatment for solid tumors. The company will launch a phase I trial at 3 sites to evaluate safe dosing levels and the product’s efficacy as a cancer therapy. Ceramide is a lipid that has demonstrated efficacy in […]

Filed Under: Featured, Food & Drug Administration (FDA), Nanoparticles, Oncology, Regulatory/Compliance Tagged With: Keystone Nano

Penn State researchers use immune cells to deliver cancer drugs

January 4, 2017 By Sarah Faulkner

Penn state researchers use immune cells to deliver cancer drugs

Researchers from the Penn State Materials Research Institute have developed a biodegradable and photoluminescent nanoparticle that are carried by immune cells to target melanoma. The team’s work was published last week in the journal Small.  “The traditional way to deliver drugs to tumors is to put the drug inside some type of nanoparticle and inject those […]

Filed Under: Featured, Immunotherapy, Nanoparticles, Oncology, Research & Development Tagged With: Penn State Materials Research Institute

Researchers develop nanodiscs to deliver personalized cancer therapy

December 28, 2016 By Sarah Faulkner

Researchers develop nanodiscs to deliver personalized cancer therapy

Researchers from the University of Michigan have developed nanodiscs that deliver a customized therapeutic vaccine to treat colon and melanoma cancer in mice. The team’s work was published in Nature Materials. “We are basically educating the immune system with these nanodiscs so that immune cells can attack cancer cells in a personalized manner,” senior author James Moon said […]

Filed Under: Featured, Immunotherapy, Nanoparticles, Oncology, Research & Development Tagged With: University of Michigan

Researchers use gold nanoparticles to deliver hepatitis C vaccine

December 20, 2016 By Sarah Faulkner

Researchers use gold nanoparticles to deliver hepatitis C vaccine

Researchers at Brigham & Women’s Hospital have developed electrically activated gold nanoparticles that can bore holes into cells’ outer membranes and allow DNA, RNA and proteins to pass through carrying their cargo. The team’s work was published in Advanced Functional Materials. The team tested its technique using a DNA vaccine against hepatitis C in a mice model. […]

Filed Under: Featured, Immunotherapy, Nanoparticles, Research & Development Tagged With: Brigham & Women's Hospital

Researchers use nanoparticles to overcome treatment-resistant breast cancer

December 15, 2016 By Sarah Faulkner

Researchers use nanoparticles to overcome treatment-resistant breast cancer

Researchers from the University of Cincinnati College of Medicine have developed RNA nanoparticles that show promise in overcoming treatment-resistant breast cancer. The team’s work was published in ACS Nano.  The researchers used a nanocarrier to target HER2-positive breast cancer and stop the production of a specific protein to prevent metastasis and render the cancer cells vulnerable to tamoxifen, […]

Filed Under: Featured, Nanoparticles, Oncology, Research & Development Tagged With: University of Cincinnati

Researchers develop nanorockets that respond to changing temperatures

December 14, 2016 By Sarah Faulkner

Researchers develop nanorockets that respond to changing temperatures

Researchers at Radboud University have developed nanorockets with temperature responsive “brakes”, enabling the carrier to stop in diseased tissues where temperatures are higher. The team’s work was published in Nature Chemistry this week. The nanocarriers can self-assemble to form functional units in any shape. “Our biggest challenge is to provide our nanorockets with various functionalities,” senior author […]

Filed Under: Featured, Nanoparticles, Research & Development Tagged With: Radboud University

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS